“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Dextran sulphate triggers platelet aggregation via direct activation of PEAR1

€3.03

SKU: product-article-19233 Category: General

Description
Reviews (0)

Description

Dextran sulphate triggers platelet aggregation via direct activation of PEAR1

Reviews

There are no reviews yet.

Be the first to review “Article: Dextran sulphate triggers platelet aggregation via direct activation of PEAR1”

You must be logged in to post a review.

Top

Article: Dextran sulphate triggers platelet aggregation via direct activation of PEAR1

Description

Reviews

Related products

Article: INTRODUCTION

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in urologic cancer

Article: Highlights in breast cancer